Recent GKOS News
- Glaukos Announces First Quarter 2024 Financial Results • Business Wire • 05/01/2024 08:05:00 PM
- Glaukos Announces the Release of its 2023 Sustainability Report • Business Wire • 04/16/2024 08:05:00 PM
- Glaukos to Release First Quarter 2024 Financial Results after Market Close on May 1 • Business Wire • 04/10/2024 11:00:00 AM
- Glaukos Receives Permanent J-code for iDose® TR (travoprost intracameral implant) • Business Wire • 04/03/2024 11:00:00 AM
- Glaukos To Present Numerous Scientific Abstracts at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting • Business Wire • 04/01/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 10:12:29 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/07/2024 09:06:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 01:09:52 AM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 03/05/2024 01:07:52 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 10:52:43 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/29/2024 10:01:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 12:00:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2024 02:29:29 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/27/2024 09:25:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 12:01:08 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/23/2024 10:23:59 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/23/2024 06:56:26 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/23/2024 05:45:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 09:10:48 PM
- Glaukos Announces Fourth Quarter and Full Year 2023 Financial Results • Business Wire • 02/21/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 09:56:48 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 10:41:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2024 11:41:27 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/12/2024 09:05:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 11:33:25 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM